Tessa Jowell Cancer Mission partnership announcement

Children with Cancer UK is delighted to announce a new partnership with The Tessa Jowell Brain Cancer Mission. We will invest £80,000 across two years to help pioneer their work into paediatric brain cancer.

Our collaboration will help their expansion into working on paediatric brain tumours. Together we will help to:

• Work with brain tumour centres to innovate and improve their services and research activity
• Generate a benchmark to understand the strengths, weaknesses, challenges and variations of care across children’ brain tumour care
• Launch a children’s arm of the Tessa Jowell Academy, an online learning and networking tool for NHS brain tumour professionals

Why is this important?

Brain tumours are the second most common form of cancer in children in the UK, with over 400 children being diagnosed each year with brain, CNS or intracranial tumours in Great Britain. There are more than 100 different types, most of which are very rare.

Over 75% of children (aged 0-14) in the UK diagnosed with central nervous system, miscellaneous intracranial and intraspinal neoplasms survive for 5 years or more (2012-2016), but this figure varies widely between tumour subgroups. There are some types of brain tumour, such as Diffuse Intrinsic Pontine Glioma (DIPG), which are considered to be incurable.

This important collaboration is another step towards our vision of a world where every child survives cancer.

Jo Elvin, CEO at Children with Cancer UK said:

Children with Cancer UK is incredibly proud to partner with the Tessa Jowell Brain Cancer Mission on this pioneering work into paediatric brain cancer. We seek opportunities to collaborate with organisations which share our vision of helping children and young people in their journey and really look forward to shaping a better future for children, teenagers and young adults who are facing a brain tumour diagnosis.

Dr Nicky Huskens, CEO at Tessa Jowell Brain Cancer Mission said:

We are thrilled to be partnering with and receive investment from Children with Cancer UK for this important programme. Not only will we be able to benefit from their extensive expertise in this area, but this investment will allow us to further expand the impact of programme to continue to improve equity and innovation in brain tumour research, treatment and care for children.

*Source Cancer Research UK